Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 17:3:90.
doi: 10.3389/fonc.2013.00090. eCollection 2013.

The tumor microenvironment: a pitch for multiple players

Affiliations

The tumor microenvironment: a pitch for multiple players

Giovanna Schiavoni et al. Front Oncol. .

Abstract

The cancer microenvironment may be conceptually regarded as a pitch where the main players are resident and non-resident cellular components, each covering a defined role and interconnected by a complex network of soluble mediators. The crosstalk between these cells and the tumor cells within this environment crucially determines the fate of tumor progression. Immune cells that infiltrate the tumor bed are transported there by blood circulation and exert a variety of effects, either counteracting or favoring tumor outgrowth. Here, we review and discuss the multiple populations composing the tumor bed, with special focus on immune cells subsets that positively or negatively dictate neoplastic progression. In this scenario, the contribution of cancer stem cells within the tumor microenvironment will also be discussed. Finally, we illustrate recent advances on new integrated approaches to investigate the tumor microenvironment in vitro.

Keywords: NK cells; T lymphocytes; cancer stem cells; dendritic cells; macrophages; myeloid-derived suppressor cells; solid tumors; tumor microenvironment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Composition of the tumor microenvironment from a mouse melanoma tumor. C57BL/6 mice were injected subcutaneously with 0.75 × 106 B16.F10 melanoma cells. After 14 days tumors were excised and sections stained with the Hematoxylin/Eosin method. (A) 40× Magnification. Blood vessel with red blood cells (red circular cells) is shown. (B) Detail of the blood vessel depicted in (A) with the indication of the various functional structures linking blood vessel and tumor milieu. Yellow arrows, tumor-infiltrating leukocytes; red arrows, red blood cells; black arrows, melanoma cells.
Figure 2
Figure 2
Role of the cancer stem cells in the development of the tumor microenvironment. Cancer progression is generated and sustained by several factors, such as epigenetic forces, somatic mutations, and EMT. On the other hand, these events lead to the generation of distinct cancer stem cell clones inside the cancer moiety, and enrich the cancer stem cell niche. During the late stages of tumor progression these stem cell clones sustain the cancer expansion with their self-renewal ability. Thus, the cancer stem cell niche can also be regarded as a reservoir of self-sustaining cells for the tumor microenvironment.

Similar articles

Cited by

References

    1. Afonina I. S., Cullen S. P., Martin S. J. (2010). Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol. Rev. 235, 105–116 - PubMed
    1. Alexe G., Dalgin G. S., Scanfeld D., Tamayo P., Mesirov J. P., Delisi C., et al. (2007). High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Cancer Res. 67, 10669–1067610.1158/0008-5472.CAN-07-0539 - DOI - PubMed
    1. Al-Shibli K. I., Donnem T., Al-Saad S., Persson M., Bremnes R. M., Busund L. T. (2008). Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin. Cancer Res. 14, 5220–522710.1158/1078-0432.CCR-08-0133 - DOI - PubMed
    1. Azogui O., Avril M. F., Margulis A., Guillard M., Caillou B., Prade M. (1991). Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cells. J. Invest. Dermatol. 97, 425–42910.1111/1523-1747.ep12481140 - DOI - PubMed
    1. Badoual C., Hans S., Fridman W. H., Brasnu D., Erdman S., Tartour E. (2009). Revisiting the prognostic value of regulatory T cells in patients with cancer. J. Clin. Oncol. 27, e5–e6 author reply e7.10.1200/JCO.2009.23.0680 - DOI - PubMed